China Advances Cervical Cancer Elimination Strategy in 2026
China integrates HPV vaccination into national programs and expands screening to combat cervical cancer, aiming for WHO elimination targets by 2030.
News & Insights Across Asia
China integrates HPV vaccination into national programs and expands screening to combat cervical cancer, aiming for WHO elimination targets by 2030.
China’s new initiative offers free HPV vaccines to 5 million girls annually, part of broader efforts to enhance women’s health and disease prevention nationwide.
China approves its first domestically developed 9-valent HPV vaccine, a major step in public health and medical innovation offering broader protection against cervical cancer.
China approves its first domestically developed nine-valent HPV vaccine, enhancing cervical cancer prevention efforts and expanding access to advanced medical solutions.